- Hall A
- Click here for Hall B
08:30-10:00 |
DIFFERENT WAYS TO EVALUATE AND CONTROL RA |
| Capsule |
Distinct biological effects of targeted therapies may be reflected in different responses, as a consequence, the search for biomarkers and best predictors of reaching remission or LDA is a potential goal. Data published shows that some multi-biomarkers tests performed well in the assessment of disease activity in RA patients. Doctors need to understund whether these new published biomarkers are useful in improving diagnosis, controlling treatments and relapses, and/or preventing either manifestations or risk factors related to the disease. Today, is there really one or a composite group of biomarkers as good at predicting a better outcome?
|
| Chairpersons | J.J. Scali, Argentina S. Gay, Switzerland |
| Biomarkers in physiopathogenic process C. Buckley, UK |
|
| Are there several biomarkers to prevent risk factors? | |
| Atherosclerosis in rheumatoid arthritis and SLE A. Doria, Italy |
|
| Objectives | Upon completion of the session, the audience will have learned:
|
10:30-12:00 |
HYDROLYSATE COLLAGEN TO TREAT OA: WHAT’S THE EVIDENCE? |
| Capsule |
Collagen derivatives (hydrolysates) have been proposed as candidates for disease-modification in OA. These derivatives are marketed as having direct chondroprotective action and reducing complaints of OA
|
| Chairpersons | M. Marty, France I. Baert, Belgium |
Debate: Are collagen derivatives (hydrolysates) realistic candidates for disease-modification in osteoarthritis?No: S.M.A. Bierma-Zeinstra, NetherlandsYes: S. Oesser, Germany Discussion |
|
| What is the place of food supplements in the treatment of OA? J. Monfort, Spain |
|
| Objective | To show the evidence for and against symptomatic and chondroprotective treatment with collagen derivatives in patients with OA |
- Hall B
- Click here for Hall A
08:30-10:00 |
CONTROVERSIAL ISSUES IN OSTEOPOROSIS AND OSTEOARTHRITIS |
|
Endorsed and organized by the Portuguese Society of Osteoporosis and Other Metabolic Bone Diseases (SPODOM) |
|
| Capsule | The goal of this symposium is to discuss several controversial issues such as the role of inflammation in the pathophysiology and the bone quality by TBS in the diagnosis of osteoporosis, including Portuguese data and experience. In addition, this session will also discuss implant problems after osteoporotic fracture healing, and finally the Portuguese data in a multicenter study addressing the problem of pain in knee osteoarthritis |
| Chairpersons | A.P. Barbosa, Portugal P. Coelho, Portugal |
| Inflammation and Osteoporosis A. Rodrigues, Portugal |
|
| Bone quality by TBS in Portuguese female population M. Mascarenhas, Portugal |
|
| To remove or not to remove implants after fracture healing J. Monteiro, Portugal |
|
| Pain in knee osteoarthritis—the Portuguese experience J. Lains, Portugal |
10:30-12:00 |
SURGERY OF OA JOINTS |
| Capsule | Cartilage lesion repair of cells by cell/matrix transplantation is a growing domain in orthopaedic surgery. The success of these surgical approaches is dependent on the post-surgical rehabilitation. Protocols of rehabilitation and guidelines of good practices have been recently formulated by physicians and scientific associations. What is the impact of the biomaterials, the surgery techniques and rehabilitation on the cartilage quality? This session will try to answer these questions |
| Chairpersons |
M.Briittberg, Sweden A. Van Ginckel, Belgium |
| Tribology of total hip replacement P. Gillet, Belgium |
|
| Cartilage adaptations after ACL injury and reconstruction: Implications for clinical management and return to play decisions? A. Van Ginckel, Belgium |
|
| Current trends in surgical repair of cartilage and fibrocartilage in large synovial joints H. Madry, Germany |
|
| Current trends in rehabilitation of cartilage problems D. Van Assche, Belgium |
|
| Objective | To provide updated protocals of rehabilitation and to implement recent guidelines for the management of pateints with cartilage lesions after surgery |
